Pacira Announces Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Pacira Announces Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia
PACIRA (NASDAQ: PCRX) Delayed: 22.99 -0.37 (1.58%)
Previous Close $23.36    52 Week High $80.25 
Open $23.56    52 Week Low $30.25 
Day High $23.72    P/E N/A 
Day Low $22.94    EPS $-2.08 
Volume 371,250       

PACIRA (NASDAQ: PCRX) Delayed: 22.99 -0.37 (1.58%)
Previous Close $23.36    52 Week High $80.25 
Open $23.56    52 Week Low $30.25 
Day High $23.72    P/E N/A 
Day Low $22.94    EPS $-2.08 
Volume 371,250